SANUWAVE Health, Inc.

NASDAQ:SNWV

Medical - Devices

Healthcare
$5.93 +1.98%

+$0.18 today

Market cap
$51.01M
Beta
1.34
P/E (TTM)
5.0
EPS (TTM)
$1.87
52W Low $8.30High $46.59

Volume 0.04M

Average 0.11M

SNWV Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

SANUWAVE Health, Inc.NASDAQ: SNWV

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development growth accelerates

Q1 FY2026 research & development of $660K rose 217.3% year over year, ahead of the +151.4% change in trailing-twelve-month research & development. Sequentially, it rose 8.9% from the prior quarter. Over 3 fiscal years it compounded at +33.6% a year.

Context

  • Research & development amounted to 3.1% of revenue in FY2025, up 1.0 pp from a year earlier.
  • Research & development increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +217.3% holds above the trailing-twelve-month pace of +151.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$660K+8.9% QoQ
Last fiscal yearDec 2025
$1.35M+101.0% YoY
LTMMar 2026
$1.81M+151.4% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+217.3%——
1 year+101.0%——
3-year CAGR+33.6%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
1.35M USD
Year-over-year change
+101.0%
4-year CAGR
+5.3%

Research & Development vs competitors

How SNWV compares with its peers on the latest reported figures

  • SNWV's LTM Mar 2026 research & development of $1.81M is the lowest of the 11 companies compared; the peer median is $20.9M.
  • Its year-over-year change of +151.4% is the 2nd highest of 11, against a peer median of -11.4%.
  • Research & development amounts to 4.1% of revenue for SNWV, versus a peer median of 24.2%.
SNWV Competitors Peer median
Research & Development for SNWV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IMRXImmuneering CorporationLTM Mar 2026$10.68B +22061.7%+5.1%—
FHTXFoghorn Therapeutics Inc.LTM Mar 2026$82.1M -9.4%-6.8%290.9%
QTRXQuanterix CorporationLTM Mar 2026$33.21M -3.4%+10.2%22.9%
SENSSenseonics Holdings, Inc.LTM Mar 2026$32.9M -13.4%-7.3%80.8%
OMOutset Medical, Inc.LTM Mar 2026$21.34M -31.8%-24.3%18.1%
INGNInogen, Inc.LTM Mar 2026$20.46M +7.3%-4.0%5.8%
NNOXNano-X Imaging Ltd.LTM Dec 2025$19.24M -4.7%-10.1%147.7%
MASS908 Devices Inc.LTM Mar 2026$13.97M -23.1%-7.7%24.2%
SGHTSight Sciences, Inc.LTM Mar 2026$12.72M -28.5%-13.9%16.0%
HSDTSolana CompanyLTM Mar 2026$2.57M -32.8%-6.3%26.8%
SNWVSANUWAVE Health, Inc.LTM Mar 2026$1.81M +151.4%+33.6%4.1%
Peer median (excluding SNWV) $20.9M-11.4%-7.1%24.2%

Competitors are the stored peer set for SNWV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue13.01M16.74M20.4M32.63M44.05M
Cost of Revenue4.99M4.33M6.04M8.08M10.08M
Gross Profit8.02M12.41M14.36M24.55M33.97M
Gross Margin61.7%74.1%70.4%75.2%77.1%
Research & Development1.1M567K579K673K1.35M
Selling, General & Admin20.28M20.03M13.57M17.67M26.79M
Operating Expenses22.17M21.36M14.9M19.13M29.02M
Depreciation & Amortization1.24M952K1.03M1.15M1.28M
EBITDA(18.9M)4.79M(9.15M)(16.56M)19.43M
EBITDA Margin-145.3%28.6%-44.9%-50.8%44.1%
Operating Income(14.14M)(8.95M)(540K)5.42M4.95M
Operating Margin-108.7%-53.5%-2.6%16.6%11.2%
Interest Income00000
Interest Expense7.1M14.13M15.62M13.64M6.25M
Other Income / Expenses(13.09M)(1.34M)(25.26M)(36.76M)6.95M
Income Before Tax(27.23M)(10.29M)(25.8M)(31.35M)11.9M
Pre-Tax Margin-209.3%-61.5%-126.5%-96.1%27.0%
Income Tax Expense28K2K4K27K86K
Net Income(27.26M)(10.29M)(25.81M)(31.37M)11.81M
Net Margin-209.5%-61.5%-126.5%-96.1%26.8%
EPS (Basic)(19.72)(7.02)(12.19)(7.03)1.38
EPS (Diluted)(19.72)(7.02)(12.19)(7.03)0.41
Weighted Avg Shares1.38M1.47M2.12M4.46M8.56M
Weighted Avg Shares (Diluted)1.38M1.47M2.12M4.46M9.08M

SANUWAVE Health, Inc.

NASDAQ:SNWV

Intrinsic Alpha fair value

Locked

Current Price

$5.93

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.